PGC-1, sirtuins and PARPs in Huntingtons disease and other neurodegenerative conditions: NAD+ to rule them all
W.GerardR
This predictable pharmacokinetic profile allows researchers to titrate GH output precisely
They had this whole high-intensity protocol, which I can't remember what it was, but their protocol for X amount of time, I'm sure it was at least a month
Supplementary information ESM 1 (download DOCX (DOCX 1210 kb) Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
One study had people on doses as high as 2,000 micrograms with no side effects